(Q54068377)

24 May 2018

title

Age at disease onset and peak ammonium level rather than interventional variables predict the neurological outcome in urea cycle disorders. (English)

1 reference

24 May 2018

author

Carlo Dionisi-Vici

5

1 reference

24 May 2018

Jiri Zeman

18

1 reference

24 May 2018

Jiri Zeman

19

1 reference

24 May 2018

Elisenda Cortès-Saladelafont

9

object named as

Elisenda Cortès-Saladelafont

1 reference

PubMed ID

27106216

24 May 2018

Vassili Valayannopoulos

3

object named as

Vassili Valayannopoulos

1 reference

PubMed ID

27106216

24 May 2018

Jolanta Sykut-Cegielska

12

object named as

Jolanta Sykut-Cegielska

1 reference

24 May 2018

0 references

Roland Posset

1

1 reference

24 May 2018

Angeles Garcia-Cazorla

2

1 reference

24 May 2018

Elisa Leão Teles

4

1 reference

24 May 2018

Anaïs Brassier

6

1 reference

24 May 2018

Alberto B Burlina

7

1 reference

24 May 2018

Peter Burgard

8

1 reference

24 May 2018

Dries Dobbelaere

10

1 reference

24 May 2018

Maria L Couce

11

1 reference

24 May 2018

Johannes Häberle

13

1 reference

24 May 2018

Allan M Lund

14

1 reference

24 May 2018

Anupam Chakrapani

15

1 reference

24 May 2018

Manuel Schiff

16

1 reference

24 May 2018

John H Walter

17

1 reference

24 May 2018

Roshni Vara

20

1 reference

24 May 2018

Stefan Kölker

21

1 reference

24 May 2018

Additional individual contributors of the E-IMD consortium

22

1 reference

24 May 2018

publication date

22 April 2016

1 reference

24 May 2018

Journal of Inherited Metabolic Disease

published in

1 reference

24 May 2018

volume

39

1 reference

24 May 2018

page(s)

661-672

1 reference

24 May 2018

issue

5

1 reference

24 May 2018

https://scigraph.springernature.com/pub.10.1007/s10545-016-9938-9

exact match

0 references

cites work

Dietary management of urea cycle disorders: European practice.

1 reference

https://api.crossref.org/works/10.1007%2FS10545-016-9938-9

Long-term outcome of patients with urea cycle disorders and the question of neonatal screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-016-9938-9

A longitudinal study of urea cycle disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-016-9938-9

Glycerol phenylbutyrate treatment in children with urea cycle disorders: pooled analysis of short and long-term ammonia control and outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-016-9938-9

Long-term outcomes in Ornithine Transcarbamylase deficiency: a series of 90 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-016-9938-9

Arginine therapy of argininosuccinase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-016-9938-9

New pathways of nitrogen excretion in inborn errors of urea synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-016-9938-9

Newborn screening programmes in Europe; arguments and efforts regarding harmonization. Part 2. From screening laboratory results to treatment, follow-up and quality assurance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-016-9938-9

Neonatal mortality and outcome at the end of the first year of life in early onset urea cycle disorders--review and meta-analysis of observational studies published over more than 35 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-016-9938-9

Hyperargininemia due to liver arginase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-016-9938-9

Survival after treatment with phenylacetate and benzoate for urea-cycle disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-016-9938-9

Current and emerging strategies for treating hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-016-9938-9

Unravelling the complex MRI pattern in glutaric aciduria type I using statistical models-a cohort study in 180 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-016-9938-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-016-9938-9

A solution to the problem of separation in logistic regression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-016-9938-9

Use of guidelines improves the neurological outcome in glutaric aciduria type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-016-9938-9

Unbiased Recursive Partitioning: A Conditional Inference Framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-016-9938-9

Behavioural and emotional problems, intellectual impairment and health-related quality of life in patients with organic acidurias and urea cycle disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-016-9938-9

Long-term outcome and intervention of urea cycle disorders in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-016-9938-9

Liver transplantation versus conservative treatment for adult-onset type II citrullinemia: our experience and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-016-9938-9

Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-016-9938-9

Diagnosis and management of glutaric aciduria type I--revised recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-016-9938-9

The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-016-9938-9

The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-016-9938-9

Networking Across Borders for Individuals with Organic Acidurias and Urea Cycle Disorders: The E-IMD Consortium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-016-9938-9

Newborn screening programmes in Europe; arguments and efforts regarding harmonization. Part 1. From blood spot to screening result

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-016-9938-9

The hyperornithinemia-hyperammonemia-homocitrullinuria syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-016-9938-9

Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-016-9938-9

Current role of liver transplantation for the treatment of urea cycle disorders: a review of the worldwide English literature and 13 cases at Kyoto University

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-016-9938-9

Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea-cycle enzymopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-016-9938-9

Retrospective survey of urea cycle disorders: Part 2. Neurological outcome in forty-nine Japanese patients with urea cycle enzymopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-016-9938-9

Urea cycle defects: management and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-016-9938-9

Cross-sectional observational study of 208 patients with non-classical urea cycle disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-016-9938-9

N-acetylglutamate synthetase deficiency: diagnosis, management and follow-up of a rare disorder of ammonia detoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-016-9938-9

Diagnosis, symptoms, frequency and mortality of 260 patients with urea cycle disorders from a 21-year, multicentre study of acute hyperammonaemic episodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-016-9938-9

The incidence of urea cycle disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-016-9938-9

Short-term survival of hyperammonemic neonates treated with dialysis

21 January 2018

1 reference

12 December 2020

Neurodevelopmental outcome of long-term therapy of urea cycle disorders in Japan

1 reference

12 December 2020

Dialysis in neonates with inborn errors of metabolism

1 reference

12 December 2020

Outcome and survival of 88 patients with urea cycle disorders: a retrospective evaluation

1 reference

12 December 2020

10.1007/S10545-016-9938-9

Identifiers

DOI

1 reference

24 May 2018

release_oj2fxo4dzbd25mjornhehpclbm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/oj2fxo4dzbd25mjornhehpclbm

24 November 2022

mapped directly with Wikidata item

PubMed ID

27106216

1 reference

24 May 2018